Underwood, Benjamin R. and Fox, Chris ORCID: https://orcid.org/0000-0001-9480-5704
(2014)
Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects.
BMJ Evidence-Based Medicine, 19 (5).
p. 181.
ISSN 2515-4478
Item Type: | Article |
---|---|
Additional Information: | Commentary on: Porsteinsson AP, Drye LT, Pollock BG, et al. Effect of citalopram on agitation in Alzheimer disease. The CitAD randomised clinical trial. JAMA 2014;311:682–91. |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
Related URLs: | |
Depositing User: | Pure Connector |
Date Deposited: | 19 Oct 2015 15:00 |
Last Modified: | 19 Apr 2023 00:54 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/54721 |
DOI: | 10.1136/ebmed-2014-110016 |
Actions (login required)
![]() |
View Item |